Sugi Predict

Sugi Predict / Compounds / SCHEMBL6165997

SCHEMBL6165997

SCHEMBL6165997

Cc1scnc1-c1cccc(C(=O)CC(=O)OC(C)(C)C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERCC5 P28715 2/20 0.36
▸ FEN1 P39748 2/20 0.36
▸ ABL1 P00519 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ PTPRC P08575 2/20 0.34
▸ RORB Q92753 2/20 0.34
▸ MAP2K4 P45985 1/20 0.34
▸ GABRA5 P31644 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ F10 P00742 1/20 0.34
▸ PRSS1 P07477 1/20 0.34
▸ PRSS2 P07478 1/20 0.34
▸ PRSS3 P35030 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ GPR55 Q9Y2T6 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164773 0.82 CPT2 (0.38) ERCC5FEN1F10PRSS1PRSS2
SCHEMBL6167366 0.80 GABRA5 (0.38) ERCC5FEN1MAPTPTPRCMAP2K4
SCHEMBL5558795 0.79 KAT6A (0.41) ERCC5FEN1MAPTUSP30ACACB
SCHEMBL6163222 0.79 KAT6A (0.47) ERCC5FEN1ABL1ACACBACACA
SCHEMBL6167654 0.78 CA12 (0.49) GABRA5MEN1NPC1POLBKMT2A
SCHEMBL5562546 0.78 AAK1 (0.43) ERCC5FEN1
SCHEMBL5562386 0.77 ERCC5 (0.43) ERCC5FEN1MAPTNPC1RAB9A
SCHEMBL5562300 0.77 KAT6A (0.44) ERCC5FEN1USP30ACACBACACA
SCHEMBL5562745 0.77 ERCC5 (0.42) ERCC5FEN1ABL1MAPK1
SCHEMBL5564018 0.77 AAK1 (0.48) ERCC5FEN1ABL1MAPTACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1264825-C Dihydro-benzo [ b ] [1,4] diazepin * -2-one derivatives as mGluR2 antagonists II HOFFMANN LA ROCHE (CH) 2006-07-19 — — CN disclosed
EP-1379511-B1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II HOFFMANN LA ROCHE (CH) 2005-07-20 — — EP disclosed
CN-1535266-A Dihydro-benzo [b][1,4] diazepin-2-one derivatives as mglur 2 antagonists II - 2004-10-06 — — CN disclosed
EP-1379511-A1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II F. HOFFMANN-LA ROCHE AG (CH) 2004-01-14 — — EP disclosed
US-6544985-B2 For therapy of acute and/or chronic neurological disorders such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits HOFFMAN-LA ROCHE INC. 2003-04-08 — — US disclosed
US-20020193367-A1 Dihydro-benzo [b] [1,4] diazepin-2-one derivatives F. HOFFMAN-LA ROCHE AG A SWISS COMPANY (CH) 2002-12-19 — — US disclosed
WO-2002083652-A1 DIHYDRO-BENZO [b] [1, 4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II F. HOFFMANN-LA ROCHE AG (CH) 2002-10-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193367-A1 Dihydro-benzo [b] [1,4] diazepin-2-one derivatives CYP1B1, GRIN2B, BDKRB1 ERCC5 3928/4885FEN1 4508/4885ABL1 3661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.